Bortezomib in the Treatment of Multiple Myeloma
Multiple Myeloma (MM) is the second most common type of blood cancer, resulting from an overproduction of cancerous infection-fighting white blood cells, known as plasma cells. Plasma cells are a crucial part of the immune system responsible for the production of antibodies. Bortezomib is a promisin...
| Corporate Author: | |
|---|---|
| Other Authors: | , , |
| Format: | Electronic eBook |
| Language: | English |
| Published: |
Basel :
Springer Basel : Imprint: Springer,
2011.
|
| Series: | Milestones in Drug Therapy
|
| Subjects: | |
| Online Access: | Full Text via HEAL-Link |
